Methods for identifying metabolites, and for developing and evaluating therapeutic agents based on the same

WO2026024676A1PCT designated stage Publication Date: 2026-01-29ENVEDA THERAPEUTICS INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2025/038586
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-07-22
Filing Date
2025-07-22
Publication Date
2026-01-29

Smart Images

  • Figure US2025038586_29012026_PF_FP_ABST
    Figure US2025038586_29012026_PF_FP_ABST
Patent Text Reader

Abstract

The present disclosure provides a method of identifying a metabolite related to a phenotype of an animal. The method includes obtaining biological samples from a first animal model having a first phenotype and a second animal model having a second phenotype, performing an analysis on the biological samples to identify metabolites with differential abundance between the models, selecting a metabolite with an increased abundance in the first model compared to the second model, administering the selected metabolite to a validation model having the second phenotype, and determining whether administration of the selected metabolite modulates the phenotype of the validation model to transition from the second phenotype toward the first phenotype. The method enables identification of potential therapeutic metabolites for treating diseases associated with metabolic imbalances.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Substances for treatment of fatty liver-related conditions

    US20210401787A1

  • IROA Metabolomics Workflow for Improved Accuracy, Identification and Quantitation

    US20220037139A1

  • Immunological effects of metabolites

    US20230330040A1

  • Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis

    WO2021113989A1